Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Animal Model Market, by Animal Type
1.1.2. Global Animal Model Market, by Technique
1.1.3. Global Animal Model Market, by Application
1.1.4. Global Animal Model Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Impact of COVID 19 on Animal Model Market
5.3.1. Impact on Market Value in 2020 and 2021
5.3.2. Clinical Trial Impact
5.3.3. Strategies to Overcome the challenges
5.3.4. Impact on Supply Chain
5.3.5. Impact on Pricing
6. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE
6.1. Overview
6.2. Mice
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.3. Rats
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.4. Pigs
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.5. Rabbits
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.6. Others
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7. GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE
7.1. Overview
7.2. CRISPR
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.1. Microinjection
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.2. Electroporation
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.3. Others
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION
8.1. Overview
8.2. Research and Development
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.1. Cardiovascular
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.2. Infectious Diseases
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.3. Metabolic Diseases
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.4. Immunological Diseases
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.5. Cancer
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.6. Diabetes
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.7. Genetic Diseases
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.8. Neurological Diseases
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.9. Others
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3. Production and Quality Control
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9. GLOBAL ANIMAL MODEL MARKET, BY END USER
9.1. Overview
9.2. Research Institutes
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.3. Educational Institutes
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.4. Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.5. Contract Research Organizations
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
10. GLOBAL ANIMAL MODEL MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitor Dashboard
11.3. Major Growth Strategy in the Global Animal Model Market
11.4. Competitive Benchmarking
11.5. The Leading Player in terms of Number of Developments in the Global Animal Model Market
11.6. Key Developments & Growth Strategies
11.6.1. New Product Launch/Service Deployment
11.6.2. Merger & Acquisition
11.6.3. Joint Ventures
11.7. Major Players Financial Matrix & Market Ratio
11.7.1. Sales & Operating Income 2019
11.7.2. Major Players R&D Expenditure 2019
12. COMPANY PROFILES
12.1. Janvier Labs
12.1.1. Company Overview
12.1.2. Products/Services Offered
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Charles River Laboratories
12.3. GenOway S.A.
12.4. Envigo
12.5. Taconic Laboratories
12.6. Transgenic, Inc.
12.7. SAGE Labs
12.8. Horizon Discovery
12.9. Crown Bioscience Inc.
12.10. Harbor Antibodies Bv (A Subsidiary of Harbor BioMed)
12.11. Others
13. APPENDIX
13.1. References
13.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
๏ก ๏ก In section 12, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
๏ก ๏ก Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.
LIST OF TABLES
TABLE 1 GLOBAL ANIMAL MODEL MARKET SYNOPSIS, 2017โ2027
TABLE 2 GLOBAL ANIMAL MODEL MARKET ESTIMATES & FORECAST, 2020โ2027 (USD MILLION)
TABLE 3 GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 4 GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 5 GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 6 GLOBAL ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 7 GLOBAL ANIMAL MODEL MARKET, BY REGION, 2020โ2027 (USD MILLION)
TABLE 8 NORTH AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 9 NORTH AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 10 NORTH AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 11 NORTH AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 12 US: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 13 US: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 14 US: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 15 US: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 16 CANADA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 17 CANADA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 18 CANADA: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 19 CANADA: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 20 LATIN AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 21 LATIN AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 22 LATIN AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 23 LATIN AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 24 EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 25 EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 26 EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 27 EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 28 WESTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 29 WESTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 30
TABLE 31 WESTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 32 WESTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 33 EASTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 34 EASTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 35 EASTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 36 EASTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020โ2027 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020โ2027 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020โ2027 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY END USERS, 2020โ2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANIMAL MODEL MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANIMAL MODEL MARKET
FIGURE 4 GLOBAL ANIMAL MODEL MARKET SHARE, BY ANIMAL TYPE, 2018 (%)
FIGURE 5 GLOBAL ANIMAL MODEL MARKET SHARE, BY TECHNIQUE, 2018 (%)
FIGURE 6 GLOBAL ANIMAL MODEL MARKET SHARE, BY APPLICATION 2018 (%)
FIGURE 7 GLOBAL ANIMAL MODEL MARKET SHARE, BY END USERS, 2018 (%)
FIGURE 8 GLOBAL ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
FIGURE 9 AMERICAS: ANIMAL MODEL MARKET SHARE BY REGION, 2018 (%)
FIGURE 10 NORTH AMERICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 11 EUROPE: ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
FIGURE 12 WESTERN EUROPE: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 13 ASIA-PACIFIC: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 14 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 15 GLOBAL ANIMAL MODEL MARKET: COMPANY SHARE ANALYSIS, 2018 (%)
FIGURE 16 JANVIER LABS: KEY FINANCIALS
FIGURE 17 JANVIER LABS: SEGMENTAL REVENUE
FIGURE 18 JANVIER LABS: REGIONAL REVENUE
FIGURE 19 CHARLES RIVER LABORATORIES: KEY FINANCIALS
FIGURE 20 CHARLES RIVER LABORATORIES.: SEGMENTAL REVENUE
FIGURE 21 CHARLES RIVER LABORATORIES: REGIONAL REVENUE
FIGURE 22 GENOWAY S.A.: KEY FINANCIALS
FIGURE 23 GENOWAY S.A.: SEGMENTAL REVENUE
FIGURE 24 GENOWAY S.A.: REGIONAL REVENUE
FIGURE 25 ENVIGO: KEY FINANCIALS
FIGURE 26 ENVIGO: SEGMENTAL REVENUE
FIGURE 27 ENVIGO: REGIONAL REVENUE
FIGURE 28 TACONIC LABORATORIES: KEY FINANCIALS
FIGURE 29 TACONIC LABORATORIES: SEGMENTAL REVENUE
FIGURE 30 TACONIC LABORATORIES: REGIONAL REVENUE
FIGURE 31 TRANSGENIC, INC.: KEY FINANCIALS
FIGURE 32 TRANSGENIC, INC.: SEGMENTAL REVENUE
FIGURE 33 TRANSGENIC, INC.: REGIONAL REVENUE
FIGURE 34 SAGE LABS: KEY FINANCIALS
FIGURE 35 SAGE LABS: SEGMENTAL REVENUE
FIGURE 36 SAGE LABS: REGIONAL REVENUE
FIGURE 37 HORIZON DISCOVERY: KEY FINANCIALS
FIGURE 38 HORIZON DISCOVERY: SEGMENTAL REVENUE
FIGURE 39 HORIZON DISCOVERY: REGIONAL REVENUE
FIGURE 40 CROWN BIOSCIENCE INC.: KEY FINANCIALS
FIGURE 41 CROWN BIOSCIENCE INC.: SEGMENTAL REVENUE
FIGURE 42 CROWN BIOSCIENCE INC.: REGIONAL REVENUE
FIGURE 43 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: KEY FINANCIALS
FIGURE 44 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: SEGMENTAL REVENUE
FIGURE 45 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: REGIONAL REVENUE
